253 related articles for article (PubMed ID: 21855341)
1. Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.
Paepe BD; Creus KK; Weis J; Bleecker JL
Neuromuscul Disord; 2012 Jan; 22(1):26-33. PubMed ID: 21855341
[TBL] [Abstract][Full Text] [Related]
2. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
4. Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism.
De Paepe B; Martin JJ; Herbelet S; Jimenez-Mallebrera C; Iglesias E; Jou C; Weis J; De Bleecker JL
Lab Invest; 2016 Aug; 96(8):872-84. PubMed ID: 27322952
[TBL] [Abstract][Full Text] [Related]
5. The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins.
De Paepe B; De Bleecker JL
Neurosci Lett; 2013 Feb; 535():18-23. PubMed ID: 23295907
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
7. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
10. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy.
Monici MC; Aguennouz M; Mazzeo A; Messina C; Vita G
Neurology; 2003 Mar; 60(6):993-7. PubMed ID: 12654966
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies.
Reimann J; Schnell S; Schwartz S; Kappes-Horn K; Dodel R; Bacher M
J Neuropathol Exp Neurol; 2010 Jun; 69(6):654-62. PubMed ID: 20467327
[TBL] [Abstract][Full Text] [Related]
12. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
13. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
14. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
[No Abstract] [Full Text] [Related]
15. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
Askanas V; Engel WK; Mirabella M
Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Fas/Fas ligand in inclusion body myositis.
Fyhr IM; Oldfors A
Ann Neurol; 1998 Jan; 43(1):127-30. PubMed ID: 9450780
[TBL] [Abstract][Full Text] [Related]
19. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.
Hohlfeld R; Engel AG; Ii K; Harper MC
N Engl J Med; 1991 Mar; 324(13):877-81. PubMed ID: 1705662
[TBL] [Abstract][Full Text] [Related]
20. Inclusion body myositis: clinical and pathological boundaries.
Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
